Literature DB >> 7248984

Venous thrombosis during multimodal treatment of primary breast carcinoma.

R B Weiss, D C Tormey, J F Holland, V E Weinberg.   

Abstract

In a cooperative group study of 433 breast cancer patients treated with 2 years of postmastectomy chemotherapy, 22 (5%) developed venous thromboses of various types. Two patients died. None of the patients had demonstrable tumor metastases at the time of the venous thrombosis, although seven had metastases a median of 11 months after the thromboses. Thirteen living patients have not had tumor recurrences. No patient developed thrombosis after the chemotherapy was completed. It is possible that one or more of the chemotherapeutic agents initiated the clotting problems. Thrombophlebitis is a possible problem occurring during adjuvant chemotherapy for breast cancer and requires prompt treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7248984

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  14 in total

1.  Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey.

Authors:  C C Kirwan; E Nath; G J Byrne; C N McCollum
Journal:  BMJ       Date:  2003-09-13

2.  A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.

Authors:  C Rella; M Coviello; F Giotta; E Maiello; P Colavito; D Colangelo; M Quaranta; G Colucci; F Schittulli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Chemotherapy enhances endothelial cell reactivity to platelets.

Authors:  M C Bertomeu; S Gallo; D Lauri; M N Levine; F W Orr; M R Buchanan
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

4.  Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.

Authors:  Giuseppe Curigliano; Alessandra Balduzzi; Anna Cardillo; Raffaella Ghisini; Giulia Peruzzotti; Laura Orlando; Rosalba Torrisi; Silvia Dellapasqua; Loredana Lunghi; Aron Goldhirsch; Marco Colleoni
Journal:  Support Care Cancer       Date:  2007-06-20       Impact factor: 3.603

Review 5.  Hemostatic alterations in cancer patients.

Authors:  F R Rickles; M Levine; R L Edwards
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

6.  Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business.

Authors:  F P Sarasin; M H Eckman
Journal:  J Gen Intern Med       Date:  1993-09       Impact factor: 5.128

7.  Coagulation tests show significant differences in patients with breast cancer.

Authors:  Faruk Tas; Leyla Kilic; Derya Duranyildiz
Journal:  Tumour Biol       Date:  2014-03-05

8.  Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.

Authors:  Cliona C Kirwan; Gerard J Byrne; Shant Kumar; Garry McDowell
Journal:  J Angiogenes Res       Date:  2009-10-24

9.  Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients.

Authors:  M Mego; U De Giorgi; K Broglio; S Dawood; V Valero; E Andreopoulou; B Handy; J M Reuben; M Cristofanilli
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

10.  Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer.

Authors:  C C Kirwan; G McDowell; C N McCollum; S Kumar; G J Byrne
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.